These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 23762870)

  • 1. Systemic delivery of tyrosine-mutant AAV vectors results in robust transduction of neurons in adult mice.
    Iida A; Takino N; Miyauchi H; Shimazaki K; Muramatsu S
    Biomed Res Int; 2013; 2013():974819. PubMed ID: 23762870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection.
    Hammond SL; Leek AN; Richman EH; Tjalkens RB
    PLoS One; 2017; 12(12):e0188830. PubMed ID: 29244806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Widespread transduction of astrocytes and neurons in the mouse central nervous system after systemic delivery of a self-complementary AAV-PHP.B vector.
    Rincon MY; de Vin F; Duqué SI; Fripont S; Castaldo SA; Bouhuijzen-Wenger J; Holt MG
    Gene Ther; 2018 Apr; 25(2):83-92. PubMed ID: 29523880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of high-dose intracisterna magna and lumbar puncture intrathecal delivery of AAV9 in mice to treat neuropathies.
    Bailey RM; Rozenberg A; Gray SJ
    Brain Res; 2020 Jul; 1739():146832. PubMed ID: 32289279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice.
    Liguore WA; Domire JS; Button D; Wang Y; Dufour BD; Srinivasan S; McBride JL
    Mol Ther; 2019 Nov; 27(11):2018-2037. PubMed ID: 31420242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracisternal delivery of AAV9 results in oligodendrocyte and motor neuron transduction in the whole central nervous system of cats.
    Bucher T; Dubreil L; Colle MA; Maquigneau M; Deniaud J; Ledevin M; Moullier P; Joussemet B
    Gene Ther; 2014 May; 21(5):522-8. PubMed ID: 24572783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective transgene expression in cerebellar Purkinje cells and granule cells using adeno-associated viruses together with specific promoters.
    Kim Y; Kim T; Rhee JK; Lee D; Tanaka-Yamamoto K; Yamamoto Y
    Brain Res; 2015 Sep; 1620():1-16. PubMed ID: 25988836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracerebroventricular injection of adeno-associated virus 6 and 9 vectors for cell type-specific transgene expression in the spinal cord.
    Dirren E; Towne CL; Setola V; Redmond DE; Schneider BL; Aebischer P
    Hum Gene Ther; 2014 Feb; 25(2):109-20. PubMed ID: 24191919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous administration of the adeno-associated virus-PHP.B capsid fails to upregulate transduction efficiency in the marmoset brain.
    Matsuzaki Y; Konno A; Mochizuki R; Shinohara Y; Nitta K; Okada Y; Hirai H
    Neurosci Lett; 2018 Feb; 665():182-188. PubMed ID: 29175632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The AAV9 Variant Capsid AAV-F Mediates Widespread Transgene Expression in Nonhuman Primate Spinal Cord After Intrathecal Administration.
    Beharry A; Gong Y; Kim JC; Hanlon KS; Nammour J; Hieber K; Eichler F; Cheng M; Stemmer-Rachamimov A; Stankovic KM; Welling DB; Ng C; Maguire CA
    Hum Gene Ther; 2022 Jan; 33(1-2):61-75. PubMed ID: 34128391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine Mutation in AAV9 Capsid Improves Gene Transfer to the Mouse Lung.
    Martini SV; Silva AL; Ferreira D; Rabelo R; Ornellas FM; Gomes K; Rocco PR; Petrs-Silva H; Morales MM
    Cell Physiol Biochem; 2016; 39(2):544-53. PubMed ID: 27384068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates.
    Gray SJ; Matagne V; Bachaboina L; Yadav S; Ojeda SR; Samulski RJ
    Mol Ther; 2011 Jun; 19(6):1058-69. PubMed ID: 21487395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes.
    Foust KD; Nurre E; Montgomery CL; Hernandez A; Chan CM; Kaspar BK
    Nat Biotechnol; 2009 Jan; 27(1):59-65. PubMed ID: 19098898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AAV9-Mediated Expression of SMN Restricted to Neurons Does Not Rescue the Spinal Muscular Atrophy Phenotype in Mice.
    Besse A; Astord S; Marais T; Roda M; Giroux B; Lejeune FX; Relaix F; Smeriglio P; Barkats M; Biferi MG
    Mol Ther; 2020 Aug; 28(8):1887-1901. PubMed ID: 32470325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of adeno-associated viral vector serotypes for spinal cord and motor neuron gene delivery.
    Snyder BR; Gray SJ; Quach ET; Huang JW; Leung CH; Samulski RJ; Boulis NM; Federici T
    Hum Gene Ther; 2011 Sep; 22(9):1129-35. PubMed ID: 21443428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates.
    Gray SJ; Nagabhushan Kalburgi S; McCown TJ; Jude Samulski R
    Gene Ther; 2013 Apr; 20(4):450-9. PubMed ID: 23303281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient CNS targeting in adult mice by intrathecal infusion of single-stranded AAV9-GFP for gene therapy of neurological disorders.
    Bey K; Ciron C; Dubreil L; Deniaud J; Ledevin M; Cristini J; Blouin V; Aubourg P; Colle MA
    Gene Ther; 2017 May; 24(5):325-332. PubMed ID: 28425480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Robust spinal motor neuron transduction following intrathecal delivery of AAV9 in pigs.
    Federici T; Taub JS; Baum GR; Gray SJ; Grieger JC; Matthews KA; Handy CR; Passini MA; Samulski RJ; Boulis NM
    Gene Ther; 2012 Aug; 19(8):852-9. PubMed ID: 21918551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders.
    Bevan AK; Duque S; Foust KD; Morales PR; Braun L; Schmelzer L; Chan CM; McCrate M; Chicoine LG; Coley BD; Porensky PN; Kolb SJ; Mendell JR; Burghes AH; Kaspar BK
    Mol Ther; 2011 Nov; 19(11):1971-80. PubMed ID: 21811247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Customized blood-brain barrier shuttle peptide to increase AAV9 vector crossing the BBB and augment transduction in the brain.
    Zhang X; Chai Z; Lee Dobbins A; Itano MS; Askew C; Miao Z; Niu H; Samulski RJ; Li C
    Biomaterials; 2022 Feb; 281():121340. PubMed ID: 34998171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.